Search

Search Constraints

You searched for: Author/Creator Gajate, P.

Search Results

1. 2602 Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC). The SPAZO study (SOGUG). (September 2015)

2. 2638 Effectiveness of 2nd-line and subsequent therapies after pazopanib (Paz) in patients (pt) with metastatic renal cell carcinoma (mRCC): Final results of the SPAZO study (SOGUG). (September 2015)

4. PD-0908 PSA Progression and survival in mCRPC patients treated with abiraterone or enzalutamide. (August 2021)